Skip to Content

'
Maria E. Cabanillas, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1998 School of Medicine, The University of Puerto Rico, San Juan, Puerto Rico, MD

Postgraduate Training

7/2007-6/2009 Fellowship, Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, Ashok Balasubramanian, MD
6/1998-6/2001 Residency, Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, Mark Farnie, MD

Selected Publications

Peer-Reviewed Original Research Articles

1. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab 94(2):386-91, 2/2009. PMID: 19017755.
2. Cabanillas ME, Lu H, Fang S, Du XL. Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures. Leuk Lymphoma 48(8):1514-21, 8/2007. PMID: 17701582.
3. Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma. Am J Clin Oncol 30(2):163-71, 4/2007. PMID: 17414466.
4. Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci 330(1):11-8, 7/2005. PMID: 16020994.
5. Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O’Brien SM. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 6(100):1179-1185, 2004.

Abstracts

1. Cabanillas ME, Mattiuzzi G, Thomas D, Vu K, Ossa G, Garcia-Manero G, Cortes J, Giles F, O’Brien S, Kantarjian H. Invasive fungal infections (IFI) in patients (pts) receiving hyper-CVAD. J Clin Oncol 23:12s, abstract 6727, 2004.

Book Chapters

1. Mora E, Cabanillas ME, Simmons R. Prevention, diagnosis, and treatment in transplant patients. In: Organ Transplant in Latin America, 1998.

Last updated: 9/22/2009